Distinct Changes in Functional Connectivity in Posteromedial Cortex Subregions during the Progress of Alzheimer's Disease

• Published in: Frontiers in neuroanatomy 2016-04, Vol.10, p.41-41
• Main Authors: Wu, Yan, Zhang, Yaqin, Liu, Yong, Liu, Jieqiong, Duan, Yunyun, Wei, Xuehu, Zhuo, Junjie, Li, Kuncheng, Zhang, Xinqin, Yu, Chunshui, Wang, Jiaojian, Jiang, Tianzi
• Format: Article
• Language: English
• Subjects: Alzheimer’s disease; Automation; Brain research; Cognitive ability; Cortex (cingulate); Cortex (parietal); Dementia; Dementia disorders; functional connectivity; Functional magnetic resonance imaging; Geriatrics; Laboratories; Memory; network; Neural networks; Neurodegenerative diseases; Neuroimaging; Neuroscience; posteromedial cortex; Psychiatry; Science; Subregions; Therapeutic applications
• ISSN: 1662-5129; 1662-5129
• DOI: 10.3389/fnana.2016.00041

Alzheimer's disease (AD) is a progressive neurodegenerative disorder which causes dementia, especially in the elderly. The posteromedial cortex (PMC), which consists of several subregions involved in distinct functions, is one of the critical regions associated with the progression and severity of AD. However, previous studies always ignored the heterogeneity of the PMC and focused on one stage of AD. Using resting-state functional magnetic resonance imaging, we studied the respective alterations of each subregion within the PMC along the progression of AD. Our data set consisted of 21 healthy controls, 18 patients with mild cognitive impairment (MCI), 17 patients with mild AD (mAD), and 18 patients with severe AD (sAD). We investigated the functional alterations of each subregion within the PMC in different stages of AD. We found that subregions within the PMC have differential vulnerability in AD. Disruptions in functional connectivity began in the transition area between the precuneus and the posterior cingulate cortex (PCC) and then extended to other subregions of the PMC. In addition, each of these subregions was associated with distinct alterations in the functional networks that we were able to relate to AD. Our research demonstrated functional changes within the PMC in the progression of AD and may elucidate potential biomarkers for clinical applications.